You are here

ASGCT

Cell and Gene Therapies Still Have Long Way to Go in Fulfilling Promise

BioSpace

Fri, 05/10/24 - 11:39 am

Preventing '3 billion visits' to FDA a year with CBER's Peter Marks

Fierce Biotech

Wed, 05/8/24 - 10:57 pm

ASGCT24: Regeneron’s Gene Therapy Shows ‘Dramatic’ Hearing Improvement in Deaf Kids

BioSpace

Wed, 05/8/24 - 11:33 am

genetic deafness